Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnoea: Protocol for an Ambispective International Real-World Study.

Background: Adherence and persistence to positive airway pressure (PAP) therapy are key factors for positive health outcomes. Home support providers (HSPs) participate in home implementation and follow-up of PAP therapy for patients with obstructive sleep apnoea (OSA). In Europe, HSP levels of service are country (or area) specific, resulting in differences in content and frequency of patient interactions.

Resourceful exploitation of sedimentary clay: Designing a dual-chambered borosilicate glass reactor system for the efficient treatment of malachite green and phenol through SCRT adsorption and 5%Fe@SRCT catalysis via CWPO, with evaluation of seed germination and fish survival.

This study presents an innovative double-walled borosilicate glass reactor system for the efficient treatment of liquid and gaseous wastewater. This reactor system allows precise temperature control, continuous pH monitoring, and controlled dosing of reagents to optimize reaction conditions. Detailed characterization was carried out by X-ray diffraction (XRD), Fourier transforms infrared spectroscopy (FTIR), BET (specific surface area) analysis, point of zero charge (PZC), and scanning electron microscopy (SEM) for the SCR, SCRT, and 5%Fe@SCRT materials.

The PAP-RES algorithm: Defining who, why and how to use positive airway pressure therapy for OSA.

Obstructive sleep apnea (OSA) is a common condition that is increasing in prevalence worldwide. Untreated OSA has a negative impact on health-related quality of life and is an independent risk factor for cardiovascular diseases. Despite available data suggesting that cardiovascular risk might differ according to clinical phenotypes and comorbidities, current approaches to OSA treatment usually take a "one size fits all" approach.

Weight telemonitoring of heart failure versus standard of care in a real-world setting: Results on mortality and hospitalizations in a 6-month nationwide matched cohort study.

Aims: Evaluating the benefit of telemonitoring in heart failure (HF) management in real-world settings is crucial for optimizing the healthcare pathway. The aim of this study was to assess the association between a 6-month application of the telemonitoring solution Chronic Care Connect™ (CCC) and mortality, HF hospitalizations, and associated costs compared with standard of care (SOC) in patients with a diagnosis of HF.

Methods And Results: From February 2018 to March 2020, a retrospective cohort study was conducted using the largest healthcare insurance system claims database in France (Système National des Données de Santé) linked to the CCC telemonitoring database of adult patients with an ICD-10-coded diagnosis of HF.